The UK Competition Authority issues provisional decision on remedies to increase competition in the private healthcare market (HCA)

CMA’s private healthcare provisional decision on remedies* The CMA has provisionally found that likely changes in London’s private healthcare market mean that extra remedies would not be proportionate. In April 2012, the Competition Commission, a predecessor body of the Competition and Markets Authority (CMA), started a market investigation into private healthcare which reported in April 2014, immediately after the establishment of the CMA. The report concluded that certain features of the markets for privately-funded healthcare services were leading to an adverse effect on competition (AEC). A

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

UK Competition Authority, The UK Competition Authority issues provisional decision on remedies to increase competition in the private healthcare market (HCA), 22 March 2016, e-Competitions March 2016, Art. N° 78818

Visites 194

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues